News & Perspective

Feb 23, 2018

Feb 23, 2018

ASP Scan (Weekly) for Feb 23, 2018

Improper prescribing in kids
XDR Pseudomonas aeruginosa
Cost-effective C diff treatment
Latent TB guidelines
Antibiotic screening method
CDC antibiotic stewardship course
Diagnostic codes and prescribing
New CARB-X funding
MRSA bacteremia and race
AMR threats in Asia-Pacific
Parasite drug effective for staph

Nov 14, 2017

Nov 14, 2017

News Scan for Nov 14, 2017

Real-time resistance tracker
Salmonella in calves
Drug-resistant malaria controversy
Hepatitis A in California

Sep 09, 2016

Sep 09, 2016

ASP News Scan for Sep 09, 2016

Resistance evolution on video
Antibiotic-resistant Salmonella in blood
Prize for drug-resistance tests
Undercount of drug-resistance deaths
AMR genes in household dust
E coli in meat samples
Malaria decline, drug resistance
ESBL E coli on pig farms

Sep 06, 2016

Sep 06, 2016

Antimicrobial Resistance Scan for Sep 06, 2016

E coli in meat samples
Malaria decline, drug resistance
ESBL E coli on pig farms

Jul 11, 2014

Jul 11, 2014

News Scan for Jul 11, 2014

Dengue vaccine
Antibiotic use up
Modified mosquitoes and WNV
Polio shot for added immunity
Avian flu 2013 recap

Oct 18, 2012

Oct 18, 2012

WHO report notes TB progress, areas for concern

(CIDRAP News) – Several developments are having an impact on reducing tuberculosis (TB) infections and deaths in several countries, but the disease's burden is still enormous, and response to multidrug-resistant TB (MDR-TB) remains slow, the World Health Organization (WHO) said yesterday in its latest report on the global TB situation.

Jan 12, 2011

Jan 12, 2011

WHO launches plan to contain drug-resistant malaria

(CIDRAP News) – Warning that the spread of artemisinin-resistant parasites threatens the world's most potent tool for fighting malaria, the World Health Organization (WHO) today released a new plan for containment.

Pages

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»